Foamix Pharmaceuticals

^{Priced, Nasdaq: FOMX}

Israeli biotech developing topical foam treatments for moderate-to-severe acne.

Industry: Health Care

First Day Return: +3.7%

FOMX

Israeli biotech developing topical foam treatments for moderate-to-severe acne.

IPO News for Foamix Pharmaceuticals

Acne cream from Israel: Sol-Gel Technologies files for an $86 million US IPO 08/29/17
Have acne? There's a gel for that! Klox Technologies files for a $75 million IPO 02/11/15
US IPO Pricing Recap: Alibaba pops 38%, represents one third of 2014 IPO market proceeds 09/19/14

IPO Data
IPO Date	09/17/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$40
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.foamix.co.il
Headquarters	Rehovot, Israel
Founded	2003
Employees at IPO	24

IPO News for Foamix Pharmaceuticals

Foamix Pharmaceuticals (FOMX) Performance